AZD8309 is an orally active antagonist of CXCR2 . AZD8309 has the ability to regulate the transmigration of neutrophils. AZD8309 can be used in the study of inflammatory diseasesIn VivoAZD8309 (50 mg/kg: p.o.: twice daily) reduces neutrophil
AZD8309 is an orally active antagonist of CXCR2 . AZD8309 has the ability to regulate the transmigration of neutrophils. AZD8309 can be used in the study of inflammatory diseasesIn VivoAZD8309 (50 mg/kg: p.o.: twice daily) reduces neutrophil
AZD8309 is an orally active antagonist of CXCR2 . AZD8309 has the ability to regulate the transmigration of neutrophils. AZD8309 can be used in the study of inflammatory diseasesIn VivoAZD8309 (50 mg/kg: p.o.: twice daily) reduces neutrophil
AZD8309 is an orally active antagonist of CXCR2 . AZD8309 has the ability to regulate the transmigration of neutrophils. AZD8309 can be used in the study of inflammatory diseasesIn VivoAZD8309 (50 mg/kg: p.o.: twice daily) reduces neutrophil